InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,266.95
(
-0.74%
)
US TECH 100
18,178.40
(
-1.14%
)
Dow Jones
38,441.54
(
-1.06%
)
Brent Oil
83.12
(
-0.31%
)
Bitcoin
67,956.82
(
0.55%
)
Post# of 251972
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Thurly

Send PM Follow Ignore
Followers 13
Posts 989
Boards Moderated 0
Alias Born 02/17/2006

Thurly

Re: iwfal post# 171253

Friday, 12/13/2013 3:56:51 AM

Friday, December 13, 2013 3:56:51 AM

Post# of 251972

The problem with TNBC is, I believe, that the ORRs don't translate in OS very well (with chemos).



I believe the thing that got people excited was the 5 in 8 complete or partial responses—which does indicate, even with the small n, that it could have some efficacy. Time will tell.

They don't break out the number of complete responses vs. partial responses. I'd like to see that data.

Corcept's own PI for TNBC starts Q114.

BSR has an update on the trial results available to subscribers.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up